Patents by Inventor Jiayan MA

Jiayan MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11796443
    Abstract: The present invention discloses a method for isolating placental trophoblast cells from cervical exfoliated cells of a pregnant woman. Based on a specific antigen or combination expressed on the surface or inside of specific trophoblast cells, the designed microfluidic sorting chip or flow cytometer is used in the method to perform cell sorting of a cell suspension of a placental trophoblast sample, thus obtaining isolated and purified placental trophoblast cells. Compared with conventional methods, the method of the present invention has the advantages of non-invasively obtaining specimens and good specificity. Moreover, the method causes low risk of infection and abortion, allows earlier sampling time and can achieve the synchronous labeling of a plurality of antigens as well as identification and sorting of characteristic fluorescence signals; and the method has greatly improved accuracy and higher reliability and broader coverage area of detection results.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: October 24, 2023
    Assignees: GUANGZHOU HYBRIBIO MEDICINE TECHNOLOGY LTD., GUANGDONG HYBRIBIO BIOTECH CO., LTD.
    Inventors: Yan Zheng, Jiayan Ma, Xiaowei Feng, Mengyu Liu, Peixuan Chen, Zhisheng Guan, Longxu Xie, Yiyuan Ge
  • Publication number: 20230228667
    Abstract: The present invention discloses a method for isolating placental trophoblast cells from cervical exfoliated cells of a pregnant woman. Based on a specific antigen or combination expressed on the surface or inside of specific trophoblast cells, the designed microfluidic sorting chip or flow cytometer is used in the method to perform cell sorting of a cell suspension of a placental trophoblast sample, thus obtaining isolated and purified placental trophoblast cells. Compared with conventional methods, the method of the present invention has the advantages of non-invasively obtaining specimens and good specificity. Moreover, the method causes low risk of infection and abortion, allows earlier sampling time and can achieve the synchronous labeling of a plurality of antigens as well as identification and sorting of characteristic fluorescence signals; and the method has greatly improved accuracy and higher reliability and broader coverage area of detection results.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 20, 2023
    Applicants: GUANGZHOU HYBRIBIO MEDICINE TECHNOLOGY LTD., GUANGDONG HYBRIBIO BIOTECH CO., LTD.
    Inventors: Yan ZHENG, Jiayan MA, Xiaowei FENG, Mengyu LIU, Peixuan CHEN, Zhisheng GUAN, Longxu XIE, Yiyuan GE